<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta name="generator" content="Hugo 0.18.1" />


<title>MBDD - A Hugo website</title>
<meta property="og:title" content="MBDD - A Hugo website">



  







<link rel="stylesheet" href="../../../../css/fonts.css" media="all">
<link rel="stylesheet" href="../../../../css/main.css" media="all">



  </head>
  <body>
    <div class="wrapper">
      <header class="header">
        <nav class="nav">
  <a href="../../../../" class="nav-logo">
    <img src="../../../../images/logo.png"
         width="50"
         height="50"
         alt="Logo">
  </a>

  <ul class="nav-links">
    
    <li><a href="../../../../about/">About</a></li>
    
    <li><a href="https://github.com/rstudio/blogdown">GitHub</a></li>
    
    <li><a href="https://twitter.com/rstudio">Twitter</a></li>
    
  </ul>
</nav>

      </header>


<main class="content" role="main">

  <article class="article">
    
    <span class="article-duration">1 min read</span>
    

    <h1 class="article-title">MBDD</h1>

    
    <span class="article-date">0001/01/01</span>
    

    <div class="article-content">
      

<h1 id="model-based-drug-development-a-rational-approach-to-efficiently-accelerate-drug-development">Model-based drug development: a rational approach to efficiently accelerate drug development.</h1>

<p>Milligan PA et al.
  <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Model-Based+Drug+Development%3A+A+Rational+Approach+to+Efficiently+Accelerate+Drug+Development">Clin Pharmacol Ther. 2013 Jun;93(6):502-14. doi: 10.1038/clpt.2013.54. Epub 2013 Mar 14.</a></p>

<h2 id="contents">Contents</h2>

<p><img src="http://i.imgur.com/yhi5UTt.png" alt="스크린샷 2016-07-01 16.18.45" />
model-based drug development (MBDD)</p>

<ul>
<li>&rdquo; 결국 모델링은 Information이 exchange할 수 있게 도와주는 tool입니다. = Knowledge Management Tool &ldquo;</li>

<li><p>종횡으로 통하게 할 수 있습니다. Integration이 가능합니다. Forward, backward 방향으로 feedback을 할 수 있습니다.</p></li>

<li><p>예 1 . Endometriosis Pain Tx - GnRH pathway targeting의 어려움을 예측해서 일찍 개발을 포기함.</p></li>

<li><p>예 2. N-arachidonyl ethanolamine (anadamide, AEA) - for pain relief</p>

<ul>
<li>additional metabolism process가 존재함을 알게됨.</li>
</ul></li>

<li><p>예 3. Systems pharmacology modeling - sodium/glucose cotransporter 2 inhibitor - SGLT2 inhibitor - 신장에서 glc 재흡수 하는데 주요 역할을 하여 T2DM에서 urinary glc excretion (UGE) 증가시킴
<img src="http://www.diabetesincontrol.com/wp-content/uploads/2013/04/www.diabetesincontrol.com_images_sglt2_sglt2-1hdiw.png" alt="enter image description here" /></p></li>

<li><p>예 4. adaptive dose-finding phase IIb study designed using clinical trial simulation</p></li>

<li><p>예 5. RA약물 Tofacitinib</p></li>
</ul>

<h2 id="question">Question</h2>

<ul>
<li>Target은 많으나 무엇이 가장 좋은지는 의문이 듭니다. MBDD가 이런 것을 해결해 줄 수 있습니다.</li>
</ul>

    </div>
  </article>

  


</main>

      <footer class="footer">
        <ul class="footer-links">
          <li>
            <a href="../../../../index.xml" type="application/rss+xml" target="_blank">RSS feed</a>
          </li>
          <li>
            <a href="https://gohugo.io/" class="footer-links-kudos">Made with <img src="../../../../images/hugo-logo.png" width="22" height="22"></a>
          </li>
        </ul>
      </footer>

    </div>
    

    

    
  </body>
</html>

